Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

TSX:QIPT - Post Discussion

Quipt Home Medical Corp > Quipt to enter diabetes market?
View:
Post by lscfa on May 16, 2024 4:45pm

Quipt to enter diabetes market?

News to me but I haven't listened to the CC yet. If disclosed there why didn't these bozos put in the news release.   



https://www.hmenews.com/article/quipt-reports-q2-increase-announces-plans-to-add-diabetes

Comment by lscfa on May 16, 2024 4:49pm
From the CC transcript. These boneheads should be disclosing this in news releases. Fire the IR dept. Our targeted initiatives aimed to drive volume-based growth through enhanced sales efforts, deepened relationships with health care providers and payers and gain access to desired geographic areas. As it relates to cross-selling opportunities, we’re strategically expanding our product offering ...more  
Comment by lscfa on May 16, 2024 11:48pm
Diabetes makes up 19% of Adapthealth's total revenues. If Quipt can do a similar %,  revenues can grow from $64M/qtr to $79M/qtr with no increase in SG&A.
Comment by lscfa on May 17, 2024 10:31am
Note: Quipt ignored diabetes acquisitions in the past but now is entertaining that idea.      Douglas Cooper Okay. And so you have relationships with suppliers now and so forth. So there's no real CapEx involved to get into this business, right? And is there any acquisition opportunities in this? Greg Crawford Yes, there could be. Those are things historically that we& ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities